A clinical comparison and long-term follow-up of topical 5-fluorouracil versus laser resurfacing in the treatment of widespread actinic keratoses
- PMID: 16912977
- DOI: 10.1002/lsm.20379
A clinical comparison and long-term follow-up of topical 5-fluorouracil versus laser resurfacing in the treatment of widespread actinic keratoses
Abstract
Background and objectives: Many treatment modalities exist for actinic keratoses (AK). Topical 5-fluorouracil (5-FU) has been one of the standard treatments. Laser resurfacing is a more recent treatment option. In the literature prospective randomized studies comparing these treatments are lacking.
Study design/patients and methods: Prospective randomized study to compare topical 5-FU with Er:YAG laser resurfacing. Fifty-five patients with multiple AK on the scalp and or the face were included. Clinical and histopathological evaluation took place at 3, 6, and 12 months after treatment.
Results: At 3, 6, and 12 months after treatment, there were significantly less recurrences in the laser group compared to the group of patients treated with 5-FU. Side effects did occur more frequently in the laser group, especially erythema and hypopigmentation.
Conclusions: Compared to treatment with topical 5-FU, Er:YAG laser resurfacing is more effective regarding recurrence rates. Although significantly more side effects occur, laser resurfacing is a useful therapeutic option especially in patients with widespread AK.
(c) 2006 Wiley-Liss, Inc.
Similar articles
-
Short incubation PDT versus 5-FU in treating actinic keratoses.J Drugs Dermatol. 2003 Dec;2(6):629-35. J Drugs Dermatol. 2003. PMID: 14711141 Clinical Trial.
-
Full face laser resurfacing: therapy and prophylaxis for actinic keratoses and non-melanoma skin cancer.Lasers Surg Med. 2004;34(2):114-9. doi: 10.1002/lsm.20012. Lasers Surg Med. 2004. PMID: 15004822
-
Effect of a 1-week treatment with 0.5% topical fluorouracil on occurrence of actinic keratosis after cryosurgery: a randomized, vehicle-controlled clinical trial.Arch Dermatol. 2004 Jul;140(7):813-6. doi: 10.1001/archderm.140.7.813. Arch Dermatol. 2004. PMID: 15262691 Clinical Trial.
-
Topical treatment of actinic keratosis with fluorouracil: is irritation associated with efficacy?J Drugs Dermatol. 2004 Jan-Feb;3(1):21-6. J Drugs Dermatol. 2004. PMID: 14964743 Review.
-
5-fluorouracil 0.5% cream for multiple actinic or solar keratoses of the face and anterior scalp.Skin Therapy Lett. 2001 Jun;6(9):1-4. Skin Therapy Lett. 2001. PMID: 11550079 Review.
Cited by
-
Actinic Keratosis and Cutaneous Squamous Cell Carcinoma.Dtsch Arztebl Int. 2019 Sep 13;116(37):616-626. doi: 10.3238/arztebl.2019.0616. Dtsch Arztebl Int. 2019. PMID: 32048593 Free PMC article. Review.
-
Actinic keratoses: a comprehensive update.J Clin Aesthet Dermatol. 2009 Jul;2(7):43-8. J Clin Aesthet Dermatol. 2009. PMID: 20729970 Free PMC article.
-
Interventions for actinic keratoses.Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD004415. doi: 10.1002/14651858.CD004415.pub2. Cochrane Database Syst Rev. 2012. PMID: 23235610 Free PMC article.
-
Three-Day Field Treatment with Ingenol Disoxate (LEO 43204) for Actinic Keratosis: Cosmetic Outcomes and Patient Satisfaction from a Phase II Trial.J Clin Aesthet Dermatol. 2017 Nov;10(11):26-32. Epub 2017 Nov 1. J Clin Aesthet Dermatol. 2017. PMID: 29399258 Free PMC article.
-
A review of actinic keratosis, skin field cancerisation and the efficacy of topical therapies.Australas J Dermatol. 2021 May;62(2):119-123. doi: 10.1111/ajd.13447. Epub 2020 Aug 25. Australas J Dermatol. 2021. PMID: 32840870 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources